HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis.

AuthorsWilma Potze, Jelle Adelmeijer, Ton Lisman
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 61 Issue 4 Pg. 1435-6 (Apr 2015) ISSN: 1527-3350 [Electronic] United States
PMID25088782 (Publication Type: Letter, Comment)
Chemical References
  • Anticoagulants
  • Morpholines
  • Thiophenes
Topics
  • Anticoagulants (administration & dosage)
  • Humans
  • Male
  • Mesenteric Veins
  • Morpholines (administration & dosage)
  • Portal Vein
  • Thiophenes (administration & dosage)
  • Venous Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: